Shareholding disclosure

Goodman & Company, Investment Counsel Ltd

Declared position

10.04%

Threshold

Crossed upwards

Timeline

Published

02.09.2009

Transaction

21.08.2009

Transfer date

21.08.2009

Voting rights breakdown

Voting rights acquired10.04%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA98V00015

Beneficial owner

Goodman & Company, Investment Counsel Ltd

Declared address

Goodman & Company, Investment Counsel Ltd, M5C 2V9 Toronto

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Goodman & Company, Investment Counsel Ltd

Newron Pharmaceuticals S.p.A.02.09.2009TA98V00015

Disclosure summary

Goodman & Company, Investment Counsel Ltd disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 02.09.2009, at 10.04% of voting rights. Notice category: Single shareholder.

Disclosed position

10.04%

Voting rights acquired

Voting rights acquired10.04%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Goodman & Company, Investment Counsel Ltd disclosed a holding in Newron Pharmaceuticals S.p.A., published on 02.09.2009.

Publication date02.09.2009

Transaction date21.08.2009

Transfer date21.08.2009

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerGoodman & Company, Investment Counsel Ltd

Declared addressGoodman & Company, Investment Counsel Ltd, M5C 2V9 Toronto

CategorySingle shareholder

Voting rights acquired10.04%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA98V00015

Source: SIX Exchange Regulation · Publication date: 02.09.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open